Related Experiment Video
Updated: May 7, 2026

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
p21-mediated RNR2 repression restricts HIV-1 replication in macrophages by inhibiting dNTP biosynthesis pathway
Awatef Allouch1, Annie David, Sarah M Amie
1Unité de Régulation des Infections Rétrovirales, Institut Pasteur, 75015 Paris, France.
Abstract:
Macrophages are a major target cell for HIV-1, and their infection contributes to HIV pathogenesis. We have previously shown that the cyclin-dependent kinase inhibitor p21 inhibits the replication of HIV-1 and other primate lentiviruses in human monocyte-derived macrophages by impairing reverse transcription of the viral genome. In the attempt to understand the p21-mediated restriction mechanisms, we found that p21 impairs HIV-1 and simian immunodeficiency virus (SIV)mac reverse transcription in macrophages by reducing the intracellular deoxyribonucleotide (dNTP) pool to levels below those required for viral cDNA synthesis by a SAM domain and HD domain-containing protein 1 (SAMHD1)-independent pathway. We found that p21 blocks dNTP biosynthesis by down-regulating the expression of the RNR2 subunit of ribonucleotide reductase, an enzyme essential for the reduction of ribonucleotides to dNTP. p21 inhibits RNR2 transcription by repressing E2F1 transcription factor, its transcriptional activator. Our findings unravel a cellular pathway that restricts HIV-1 and other primate lentiviruses by affecting dNTP synthesis, thereby pointing to new potential cellular targets for anti-HIV therapeutic strategies.
Insights
The cyclin-dependent kinase inhibitor p21 restricts HIV-1 replication in macrophages by depleting deoxyribonucleotides (dNTPs) through a novel pathway. This impacts viral cDNA synthesis and offers new therapeutic targets for HIV.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Macrophages are key targets for HIV-1, contributing to disease progression.
- Previous work showed p21 inhibits HIV-1 and primate lentivirus replication in macrophages by impairing reverse transcription.
Purpose of the Study:
- To elucidate the p21-mediated restriction mechanisms against HIV-1 and SIVmac in macrophages.
- To identify the specific cellular pathways involved in p21's antiviral activity.
Main Methods:
- Investigated the effect of p21 on intracellular deoxyribonucleotide (dNTP) pools during lentiviral infection.
- Analyzed the expression of ribonucleotide reductase (RNR) subunits and transcription factors like E2F1.
- Utilized human monocyte-derived macrophages and HIV-1/SIVmac infection models.
Main Results:
- p21 reduces intracellular dNTP levels in macrophages, impairing HIV-1 and SIVmac reverse transcription via a SAMHD1-independent pathway.
- p21 down-regulates RNR2 expression, a key enzyme in dNTP biosynthesis.
- p21 inhibits RNR2 transcription by repressing the E2F1 transcription factor.
Conclusions:
- p21 restricts primate lentivirus replication by inhibiting dNTP synthesis through the RNR2/E2F1 pathway.
- This cellular mechanism presents a novel target for developing anti-HIV therapies.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Negative Regulator Molecules
Viruses with RNA Genomes
Retrovirus Life Cycles
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Inhibition of Cdk Activity

